EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dysregulation of TLR Signaling-Associated Gene Expression in X-linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease Expression

Marcelo Teocchi, Thaís de Andrade Eugênio, Lia Furlaneto Marega, Isabella Quinti, Maria Marluce Dos Santos Vilela

Journal of Innate Immunity · 2024

DOI: 10.1159/000540082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Innate Immunity, 2024. Verfasst von Marcelo Teocchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pediatric Immunology, Center for Investigation in Pediatrics, University of Campinas Medical School (FCM-UNICAMP), Campinas, Brazil. Hauptthemen laut MEDLINE: Agammaglobulinemia, Genetic Diseases, X-Linked, Agammaglobulinaemia Tyrosine Kinase, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In X-linked agammaglobulinemia (XLA), the diversity of BTK variants complicates the study of genotype-phenotype correlations. Since BTK negatively regulates toll-like receptors (TLRs), we investigated if distinct BTK mutation types selectively modulate TLR pathways, affecting disease expression.

Methods

Using RT-qPCR, we quantified ten TLR signaling-related genes in XLA patients with missense (n=3) and nonsense (n=5) BTK mutations and healthy controls (n=17).

Results

BTK, IRAK2, PIK3R4, REL, TFRC, and UBE2N were predominantly downregulated, while RIPK2, TLR3, TLR10, and TLR6 showed variable regulation. The missense XLA group exhibited significant downregulation of IRAK2, PIK3R4, REL, and TFRC, and upregulation of TLR3 and/or TLR6.

Conclusion

Hypo-expression of TLR3, TLR6, and TLR10 may increase susceptibility to infections, while hyper-expression might contribute to chronic inflammatory conditions like arthritis or inflammatory bowel disease. Our findings shed light on the important inflammatory component characteristic of some XLA patients, even under optimal therapeutic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgammaglobulinemiaGenetic Diseases, X-LinkedAgammaglobulinaemia Tyrosine KinaseSignal TransductionGenetic Association StudiesToll-Like ReceptorsHumansMaleAdolescentChildGene Expression RegulationAdultChild, PreschoolYoung AdultFemaleMutation

Stichwörter der Autor:innen

B-lymphocytesBruton’s tyrosine kinaseGene expression profilingNF-kappaBToll-like receptorX-linked agammaglobulinemia

Substanzen

Agammaglobulinaemia Tyrosine KinaseBTK protein, humanToll-Like Receptors

Autor:innen und Institutionen

  • Laboratory of Pediatric Immunology, Center for Investigation in Pediatrics, University of Campinas Medical School (FCM-UNICAMP), Campinas, Brazil.
  • Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Zitieren

APA

Teocchi, M., de Andrade Eugênio, T., Furlaneto Marega, L., Quinti, I., & Dos Santos Vilela, M. M. (2024). Dysregulation of TLR Signaling-Associated Gene Expression in X-linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease Expression. Journal of Innate Immunity. https://doi.org/10.1159/000540082

Vancouver

Teocchi M, de Andrade Eugênio T, Furlaneto Marega L, Quinti I, Dos Santos Vilela MM. Dysregulation of TLR Signaling-Associated Gene Expression in X-linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease Expression. Journal of Innate Immunity. 2024. doi:10.1159/000540082

BibTeX
@article{Teocchi2024,
  author = {Teocchi, Marcelo and de Andrade Eugênio, Thaís and Furlaneto Marega, Lia and Quinti, Isabella and Dos Santos Vilela, Maria Marluce},
  title = {Dysregulation of TLR Signaling-Associated Gene Expression in X-linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease Expression},
  journal = {Journal of Innate Immunity},
  year = {2024},
  doi = {10.1159/000540082}
}
Kostenlos starten →